Good morning :)
$
₹
C

Conexeu Sciences Inc. Common Stock

CNXU

NASDAQ
C

Conexeu Sciences Inc. Common Stock

CNXU

NASDAQ
$4.264.48% (-0.20)
$
₹
$4.264.48% (-0.20)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
Loading...
1D
1W
1M
1Y
5Y
Max

Healthcare

Biotechnology

Micro Cap

With a market cap of $125.2M the stock is ranked 4531

Key Metrics

Key Metrics

PE TTM
PE TTM

Close price divided by the earnings per share for the trailing twelve months

—
PB
PB

Close price divided by the book value per share at the end of the most recent quarter

18.29
EPS TTM
EPS TTM

Net profit earned per share over the trailing twelve months (sum of the last 4 quarters)

$-0.35
PEG Ratio
PEG Ratio

Price-to-Earnings (P/E) ratio divided by the forecasted annual earnings per share (EPS) growth rate over the next five years

—
Profit Margin
Profit Margin

Net profit divided by the total revenue for the most recent financial year

0%
Dividend Yield
Dividend Yield

Annual dividend per share for the trailing twelve months divided by the close price

—

Company Profile

Conexeu Sciences Inc. develops collagen-based regenerative tissue scaffold products for applications in medical aesthetics and tissue repair. The company provides patented collagen-based scaffold products, including a collagen extracellular matrix (ECM) scaffold platform for use in medical aesthetics, wound care, tissue repair, facial rejuvenation, and large-volume body contouring such as face, breast, and butt volume restoration. Its CXU collagen gel is an investigational product targeting therapeutic and aesthetic indications, supporting tissue regeneration and aiming to minimize inflammation or fibrosis. The company's solutions are supported by preclinical and peer-reviewed data and are positioned as alternatives to conventional fillers or implants, with products currently investigational and pending regulatory clearance for certain applications. The company serves clients in the beauty, aesthetics, regenerative medicine, and medical sectors, including clinicians and professionals involved in facial rejuvenation, body contouring, wound care, and tissue repair. The company was founded in 2022 and is based in Reno, Nevada.
Conexeu Sciences Inc. develops collagen-based regenerative tissue scaffold products for applications in medical aesthetics and tissue repair. The company provides patented collagen-based scaffold products, including a collagen extracellular matrix (ECM) scaffold platform for use in medical aesthetics, wound care, tissue repair, facial rejuvenation, and large-volume body contouring such as face, breast, and butt volume restoration. Its CXU collagen gel is an investigational product targeting therapeutic and aesthetic indications, supporting tissue regeneration and aiming to minimize inflammation or fibrosis. The company's solutions are supported by preclinical and peer-reviewed data and are positioned as alternatives to conventional fillers or implants, with products currently investigational and pending regulatory clearance for certain applications. The company serves clients in the beauty, aesthetics, regenerative medicine, and medical sectors, including clinicians and professionals involved in facial rejuvenation, body contouring, wound care, and tissue repair. The company was founded in 2022 and is based in Reno, Nevada.

Peers

Peers

AbbVie Inc
ABBV
AbbVie Inc
P/E Ratio
70.27
70.27
1Y Return
19.08%
19.08%
Buy Reco %
57.14
57.14
Amgen Inc
AMGN
Amgen Inc
P/E Ratio
24.43
24.43
1Y Return
41.43%
41.43%
Buy Reco %
46.87
46.87
Gilead Sciences Inc
GILD
Gilead Sciences Inc
P/E Ratio
—
—
1Y Return
27.55%
27.55%
Buy Reco %
63.33
63.33
Vertex Pharmaceuticals Inc
VRTX
Vertex Pharmaceuticals Inc
P/E Ratio
30.83
30.83
1Y Return
31.43%
31.43%
Buy Reco %
52.94
52.94
Regeneron Pharmaceuticals Inc
REGN
Regeneron Pharmaceuticals Inc
P/E Ratio
20.06
20.06
1Y Return
45.3%
45.3%
Buy Reco %
76.00
76.00

Peers & Comparison

Peers & Comparison

Comparing 2 stocks from
HealthcareBiotechnology

Valuation

Returns

Forecast

StockPE TTMPE TTMPBPBPEG RatioPEG Ratio
Conexeu Sciences Inc. Common Stock -18.29-
AbbVie Inc70.2750.450.36
Amgen Inc24.4320.222.10

Price Comparison

Price Comparison

1 Month

1 Year

5 Years

Loading...

Financials

Financials

Income

Balance Sheet

Cash Flow

-0.2
-0.4
-1.7
-2.3
Q1 2025
Q2 2025
Q1 2026
Q2 2026
Revenue
Net Income
Financial YearQ1 2025Q2 2025Q1 2026Q2 2026
Total Revenue0000
Net Income-0.29-0.45-1.71-2.30
Net Profit Margin----
See CostsAll values in $ Million

Frequently asked questions

Frequently asked questions

  1. Conexeu Sciences Inc. Common Stock (CNXU) share price today is $4.26 as of September 11, 2026 at 1:30 AM IST. The stock touched a day high of $4.42 and a day low of $4.22.

  2. Conexeu Sciences Inc. Common Stock stock trades on NASDAQ under the ticker symbol CNXU.

  3. Conexeu Sciences Inc. Common Stock's market capitalization is $125.22M as of September 11, 2026 at 1:30 AM IST.

  4. Conexeu Sciences Inc. Common Stock's price-to-earnings (P/E) ratio is N/A as of September 10, 2026.

  5. Conexeu Sciences Inc. Common Stock's price-to-book (P/B) ratio is 18.29 as of September 10, 2026.

  6. Yes, You can buy Conexeu Sciences Inc. Common Stock shares from India through Tickertape, via our partnership with ViewTrade IFSC under the IFSCA Global Access framework, subject to RBI’s Liberalised Remittance Scheme (LRS) limits.

  7. Indian investors can buy Conexeu Sciences Inc. Common Stock shares in three steps: 1. Search Conexeu Sciences Inc. Common Stock on the Tickertape app and tap Invest. 2. Complete your one-time digital KYC. 3. Fund your account and buy from as low as $1 via fractional shares.

  8. Since Conexeu Sciences Inc. Common Stock trades in USD, an Indian investor's INR returns depend on both the stock's price movement and the USD-INR exchange rate. If the rupee depreciates against the dollar, INR returns are boosted beyond the stock's USD return; if the rupee appreciates, INR returns are reduced.

  9. Indian investors can start investing in Conexeu Sciences Inc. Common Stock (CNXU) shares from as little as $1 through fractional ownership on Tickertape - for example, $10 buys approximately 2.3474 shares at the current price of $4.26.

Loading...